U.S. markets close in 2 hours 42 minutes
  • S&P 500

    3,784.02
    -11.52 (-0.30%)
     
  • Dow 30

    30,936.64
    -54.88 (-0.18%)
     
  • Nasdaq

    13,076.74
    -35.90 (-0.27%)
     
  • Russell 2000

    2,130.30
    -25.05 (-1.16%)
     
  • Crude Oil

    52.23
    -1.34 (-2.50%)
     
  • Gold

    1,830.70
    -20.70 (-1.12%)
     
  • Silver

    24.82
    -0.99 (-3.83%)
     
  • EUR/USD

    1.2090
    -0.0065 (-0.53%)
     
  • 10-Yr Bond

    1.0870
    -0.0420 (-3.72%)
     
  • GBP/USD

    1.3596
    -0.0095 (-0.70%)
     
  • USD/JPY

    103.8200
    +0.0040 (+0.00%)
     
  • BTC-USD

    36,103.30
    -1,735.34 (-4.59%)
     
  • CMC Crypto 200

    694.26
    -40.88 (-5.56%)
     
  • FTSE 100

    6,735.71
    -66.25 (-0.97%)
     
  • Nikkei 225

    28,519.18
    -179.08 (-0.62%)
     

Mirati Therapeutics Inc (MRTX) President & CEO Charles M Baum Sold $949,069 of Shares

GuruFocus.com
·2 min read

- By insider

President & CEO of Mirati Therapeutics Inc (30-Year Financial, Insider Trades) Charles M Baum (insider trades) sold 4,511 shares of MRTX on 01/06/2021 at an average price of $210.39 a share. The total sale was $949,069.


Mirati Therapeutics Inc is a biotechnology company. The company's focuses on precision medicine for oncology therapeutics. The company provides bioavailable inhibitors with distinct target profiles aiming to treat cancer patients. Mirati Therapeutics Inc has a market cap of $10.94 billion; its shares were traded at around $217.480000 with and P/S ratio of 790.83. Mirati Therapeutics Inc had annual average EBITDA growth of 9.30% over the past ten years. GuruFocus has detected 3 severe warning signs with Mirati Therapeutics Inc. .

CEO Recent Trades:

  • President & CEO Charles M Baum sold 4,511 shares of MRTX stock on 01/06/2021 at the average price of $210.39. The price of the stock has increased by 3.37% since.

  • President & CEO Charles M Baum sold 40,000 shares of MRTX stock on 12/18/2020 at the average price of $234.48. The price of the stock has decreased by 7.25% since.

Directors and Officers Recent Trades:

  • SVP, Chief Accounting Officer Vickie S Reed sold 779 shares of MRTX stock on 01/07/2021 at the average price of $212.23. The price of the stock has increased by 2.47% since.

  • EVP, Chief Commercial Officer Benjamin Hickey sold 2,078 shares of MRTX stock on 01/07/2021 at the average price of $216.33. The price of the stock has increased by 0.53% since.

  • EVP, COO Daniel Faga sold 2,625 shares of MRTX stock on 01/07/2021 at the average price of $216.33. The price of the stock has increased by 0.53% since.

  • EVP, Chief Scientific Officer Jamie Christensen sold 1,459 shares of MRTX stock on 01/06/2021 at the average price of $210.39. The price of the stock has increased by 3.37% since.

  • Director Henry J Fuchs sold 10,000 shares of MRTX stock on 12/15/2020 at the average price of $233.39. The price of the stock has decreased by 6.82% since.

For the complete insider trading history of MRTX, click here

.This article first appeared on GuruFocus.